Vimarsana.com

Latest Breaking News On - Zemin zhang - Page 1 : vimarsana.com

The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements

The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements
thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.

Guangdong
Jilin
China
Thailand
Shenzhen
Peking
Beijing
Gang-cao
Anhui
Guangzhou
Guangming
United-states

Researchers Show How COVID-19 Virus Triggers Immune Signaling "Storm"

Share this article Share this article NEW YORK, May 14, 2021 /PRNewswire/ -- Researchers have discovered new ways in which the COVID-19 virus causes human immune cells to overreact, a deadly part of the disease. Led by researchers from NYU Grossman School of Medicine and the Perlmutter Cancer Center at NYU Langone Health, the new study found that SARS-CoV-2, the pandemic virus, interacts with specific proteins on immune cells, causing these cells to release abnormally high levels of immune signaling proteins called cytokines (a "cytokine storm"). These cytokines, in turn, cause fluid buildup in the lungs and makes it hard to breathe.

China
Uzhilin
Zhejiang
Shanghai
Jun-wang
Henan
Peng-lin
Fujian
Beijing
Siyuan
Jiangsu
Ming-zhou

AACR: Single-cell analysis transforming cancer research

AACR: Single-cell analysis transforming cancer research
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Peking
Beijing
Chinese
American
Zemin-zhang
American-association-for-cancer-research
Landscape-of-cancer-research
Biomedical-pioneering-innovation-center
Chinese-society-of-clinical-oncology
American-association

vimarsana © 2020. All Rights Reserved.